Cargando…
Routine clozapine assay monitoring to improve the management of treatment-resistant schizophrenia
AIMS AND METHOD: Routine therapeutic drug monitoring in clozapine therapy has previously not been considered justifiable. Using observational data, the clinical utility of annual clozapine assay monitoring is explored within a large mental health trust. RESULTS: After the introduction of routine mon...
Autores principales: | Kitchen, David, Till, Alex, Xavier, Panchu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768514/ https://www.ncbi.nlm.nih.gov/pubmed/33910673 http://dx.doi.org/10.1192/bjb.2021.36 |
Ejemplares similares
-
Author's Reply. RE: Routine clozapine assay monitoring to improve the management of treatment-resistant schizophrenia
por: Kitchen, David
Publicado: (2023) -
RE: Routine clozapine assay monitoring to improve the management of treatment-resistant schizophrenia
por: Gupta, Sumeet, et al.
Publicado: (2023) -
Management of patients with Clozapine Resistant Schizophrenia
por: Rajendran*, Nithya Ragavi, et al.
Publicado: (2022) -
Effectiveness of clozapine in treatment-resistant schizophrenia
por: Raguraman, Janakiraman, et al.
Publicado: (2005) -
Barriers to using clozapine in treatment-resistant schizophrenia: systematic review
por: Farooq, Saeed, et al.
Publicado: (2019)